IN3 COST-EFFECTIVENESS OF VORICONAZOLE VERSUS LIPOSOMALAMPHOTERICIN B FOR INVASIVE ASPERGILLOSIS INFECTION IN THE UK
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67201-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)67201-4/fulltext
Section Title :
Section Order :
357
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67201-4&doi=10.1016/S1098-3015(10)67201-4